Position in ASND
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,414,748
+$12,305,584 QoQ
Shares Held
76,540
+115.9% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#76
of 307 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Derivatives in ASND
reported options exposure · as of Dec 31, 2025CallValue
$21,324
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,205,173 across 455 Biotechnology names. ASND ranks #16 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in ASND
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,414,748 | 76,540 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $8,109,164 | 35,453 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,397,670 | 11,244 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $21,324 | 100 | Call | Sole | 2026-02-13 | |
| 2025-09-30 | $2,143,569 | 10,782 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $2,058,945 | 11,929 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $1,619,385 | 10,390 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $3,989,125 | 28,976 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $2,797,472 | 18,736 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $2,591,765 | 19,004 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $10,959,825 | 72,500 | Put | Sole | 2026-03-24 | |
| 2024-03-31 | $3,185,453 | 21,072 | Shares | Sole | 2026-03-24 | |
| 2024-03-31 | $18,098,072 | 119,720 | Call | Sole | 2026-03-24 | |
| 2023-12-31 | $2,182,083 | 17,325 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $2,833,875 | 22,500 | Put | Sole | 2026-03-24 | |
| 2023-12-31 | $2,833,875 | 22,500 | Call | Sole | 2026-03-24 | |
| 2023-09-30 | $1,637,014 | 17,482 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $54,264 | 608 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $7,387,672 | 68,902 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $6,925,625 | 56,707 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $12,889,016 | 124,821 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $13,483,290 | 145,044 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $101,516 | 865 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $84,350 | 627 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,104,637 | 38,300 | Put | Sole | 2021-11-09 | |
| 2021-09-30 | $5,532,266 | 34,709 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $90,111 | 685 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $520,546 | 4,039 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $723,324 | 4,337 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $635,952 | 4,121 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $589,085 | 3,983 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $37,048 | 329 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||